Latest current cash for SNPHF: $78B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Santen Pharmaceutical , Ltd. (SNPHF) currently reports a current cash of $78B as of June 2026. That compares with $85B in the prior-year period — down 8.1% year over year. Use the charts on this page to explore Santen Pharmaceutical , Ltd.'s current cash history and peer comparisons.
Santen Pharmaceutical , Ltd.'s current cash decreased from $85B to $78B — a 8.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Santen Pharmaceutical , Ltd. reported $78B in current cash as of June 2026. That compares with $85B in the prior-year period — down 8.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current cash of $78B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Santen Pharmaceutical , Ltd., and consider following SNPHF for alerts when major investors trade the stock.